CLINICAL AND PHARMACOECONOMIC ANALYSIS OF CARBAPENEMS (MEROPENEM, IMIPENEM AND DORIPENEM) IN NOSOCOMIAL PNEUMONIA TREATMENT

CLINICAL AND PHARMACOECONOMIC ANALYSIS OF CARBAPENEMS (MEROPENEM, IMIPENEM AND DORIPENEM) IN NOSOCOMIAL PNEUMONIA TREATMENT

the article presents the results of a retrospective study conducted in the period from 2008 to 2011 in Moscow’s hospitals. The aim of the study was to compare the clinical and pharmacoeconomical efficacy of carbapenems in nosocomial pneumonia treatment. The study included 87 patients divided into 3...

Full description

Bibliographic Details
Main Authors:	I. I. Shteynberg, S. K. Zyryanov, Yu. B. Belousov
Format:	Article
Language:	Russian
Published:	IRBIS LLC 2015-03-01
Series:	Фармакоэкономика
Subjects:	nosocomial pneumonia carbapenem meropenem imipenem doripenem
Online Access:	https://www.pharmacoeconomics.ru/jour/article/view/54

Similar Items

Overview and Insights into Carbapenem Allergy
by: Yuman Lee, et al.
Published: (2019-08-01)

In vitro activity of meropenem, imipenem, cefepime, cefoxitin and ciprofloxacin against multiresistant Klebsiella pneumoniae.
by: P Pruekprasert, et al.
Published: (2006-06-01)

Carbapenem-Only Combination Therapy against Multi-Drug Resistant <i>Pseudomonas aeruginosa</i>: Assessment of In Vitro and In Vivo Efficacy and Mode of Action
by: Brendan Mackay, et al.
Published: (2022-10-01)

Treatment of nosocomial pneumonia: an experience with meropenem
by: Santos Sigrid S., et al.
Published: (2001-01-01)

Treatment of nosocomial pneumonia: an experience with meropenem
by: Sigrid S. Santos, et al.

Carbapenem-Hydrolyzing Metallo-ß-Lactamase from a Nosocomial Isolate of Pseudomonas aeruginosa in France
by: Laurent Poirel, et al.
Published: (2000-02-01)

Clinical efficacy of ertapenem vs. other carbapenems for the treatment of extended-spectrum-β-lactamase-producing Enterobacterales infection: A systematic review and meta-analysis
by: Po-Yu Huang, et al.
Published: (2023-06-01)

Comparison of in Vitro Activity of Doripenem versus Old Carbapenems against Pseudomonas Aeruginosa Clinical Isolates from both CF and Burn Patients
by: Reza Bigverdi, et al.
Published: (2013-02-01)

Doripenem in the Treatment of Patients with Nosocomial Pneumonia: A Meta-Analysis
by: Chienhsiu Huang, et al.
Published: (2022-07-01)

Carbapenem Resistance in Klebsiella pneumoniae Not Detected by Automated Susceptibility Testing
by: Fred C. Tenover, et al.
Published: (2006-08-01)

Nozokomiyal Pseudomonas Aerugınosa İzolatlarında Doripenem Duyarlılık Oranlarının E-Test Yöntemiyle Araştırılması
by: Abdullah Bektaş, et al.
Published: (2011-09-01)

Carbapenem resistance associated with coliuria among outpatient and hospitalised urology patients
by: A.A. Adegoke, et al.
Published: (2022-07-01)

Review of In Vitro Efficacy of Ceftazidime-Avibactam, Meropenem-Vaborbactam and Imipenem-Relebactam in Carbapenemase Producing Klebsiella pneumoniae Isolates
by: Özlem AYDEMİR, et al.
Published: (2023-09-01)

The importance of meropenem resistance, rather than imipenem resistance, in defining carbapenem-resistant Enterobacterales for public health surveillance: an analysis of national population-based surveillance
by: Chiaki Ikenoue, et al.
Published: (2024-02-01)

Actividad in vitro de doripenem comparado con meropenem frente a aislamientos de Pseudomonas aeruginosa en un centro asistencial de tercer nivel de Bogotá (Colombia) Activity of Doripenem compared to Meropenem against Pseudomonas aeruginosa isolates at Tertiary Care Teaching Hospital in Bogotá (Colombia)
by: Adriana Jiménez, et al.
Published: (2012-12-01)

Prevalence of Carbapenem Resistance in Acinetobacter baumannii Isolates from Burn and Non-Burn Patients in Tehran
by: Zahra Ghareboghy Sarmad, et al.
Published: (2015-09-01)

Prevalence of Carbapenem Resistance in Acinetobacter baumannii Isolates from Burn and Non Burn Patients in Tehran
by: Zahra Ghareboghy-Sarmad, et al.
Published: (2015-11-01)

Fingolimod Promotes Antibacterial Effect of Doripenem against Carbapenem-Resistant <i>Escherichia coli</i>
by: Hye-Won Jin, et al.
Published: (2022-08-01)

Detection of aztreonam, meropenem and imipenem resistant Gram negative bacteria from inpatient department in Federal Medical Center (FMC), Birnin, Kebbi, Nigeria
by: Bilyaminu Jega, et al.
Published: (2024-02-01)

Effectiveness and Nephrotoxicity of Loading Dose Colistin–Meropenem versus Loading Dose Colistin–Imipenem in the Treatment of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Infection
by: Wasan Katip, et al.
Published: (2022-06-01)

In vitro activity of biapenem and other carbapenems against Russian clinical isolates of Pseudomonas aeruginosa, Acinetobacter spp., and Enterobacterales
by: Kozlov R.S., et al.
Published: (2021-09-01)

DORIPENEM IN THERAPY OF PATIENTS WITH COMPLICATED UROLOGIC INFECTION
by: G. G. KRIVOBORODOV, et al.
Published: (2016-12-01)

Exogenous glutathione reverses meropenem resistance in carbapenem-resistant Klebsiella pneumoniae
by: Juan Yi, et al.
Published: (2023-12-01)

Phenotypic detection of Metallo-β-Lactamase in imipenem-resistant Pseudomonas aeruginosa and Stenotrophomonas maltophilia at Schiphra Hospital of Ouagadougou in Burkina Faso
by: Boukaré Kaboré, et al.
Published: (2022-02-01)

Carbapenem Combinations for Infections Caused by Carbapenemase-Producing <i>Pseudomonas aeruginosa</i>: Experimental In Vitro and In Vivo Analysis
by: Soraya Herrera-Espejo, et al.
Published: (2022-09-01)

Therapeutic drug monitoring of imipenem/cilastatin and meropenem in critically ill adult patients
by: Xi You, et al.
Published: (2024-03-01)

Superinfection rate among the patients treated with carbapenem versus piperacillin/tazobactam: Retrospective observational study
by: Hessa Al Muqati, et al.
Published: (2021-03-01)

<i>Klebsiella pneumoniae</i> Susceptibility to Carbapenem/Relebactam Combinations: Influence of Inoculum Density and Carbapenem-to-Inhibitor Concentration Ratio
by: Maria V. Golikova, et al.
Published: (2022-06-01)

MODERN ANTIBACTERIAL THERAPY IN HOSPITAL-ACQUIRED PNEUMONIA
by: V. B. Beloborodov, et al.
Published: (2017-11-01)

Detection of OXA-Type Carbapenemase Genes in Acinetobacter baumannii Isolates from Nosocomial Infections in Isfahan Hospitals, Iran
by: Vajihe Karbasizade, et al.
Published: (2016-01-01)

Detection of OXA-Type Carbapenemase Genes in Acinetobacter baumannii Isolates from Nosocomial Infections in Isfahan Hospitals, Iran
by: Vajihe Karbasizade, et al.
Published: (2016-02-01)

First description of antimicrobial resistance in carbapenem-susceptible Klebsiella pneumoniae after imipenem treatment, driven by outer membrane remodeling
by: Xuebin Tian, et al.
Published: (2020-07-01)

The Comparison of Various Antibiotics Sensitivities in Uropathogen Escherichia coli Strains Producing Community and Hospital-Acquired Extended Spectrum Beta-Lactamase
by: Şafak ÖZER BALİN, et al.
Published: (2015-06-01)

Predicting the Effects of Carbapenem/Carbapenemase Inhibitor Combinations against KPC-Producing <i>Klebsiella pneumoniae</i> in Time-Kill Experiments: Alternative versus Traditional Approaches to MIC Determination
by: Alla V. Filimonova, et al.
Published: (2021-12-01)

In vitro activity of ceftazidime-avibactam, imipenem-relebactam, aztreonam-avibactam, and comparators toward carbapenem-resistant and hypervirulent Klebsiella pneumoniae isolates
by: Dan Li, et al.
Published: (2023-12-01)

Activities of imipenem-relebactam combination against carbapenem-nonsusceptible Enterobacteriaceae in Taiwan
by: Tsung-Ying Yang, et al.
Published: (2022-02-01)

Prevalency of imipenem-resistant bacterial strains isolated from hospital and accuracy of Iranian imipenem disc product
by: Ahmadi A, et al.
Published: (2015-03-01)

Evaluating the appropriateness of carbapenem and piperacillin-tazobactam prescribing in a tertiary care hospital in Saudi Arabia
by: Nada A Alsaleh, et al.
Published: (2020-11-01)

Method Development for Determination of Doripenem in Human Plasma via Capillary Electrophoresis Coupled with Field-Enhanced Sample Stacking and Sweeping
by: Hsin-Hua Liang, et al.
Published: (2023-09-01)

METALLO-ß-LACTAMASE PRODUCTION IN IMIPENEM RESISTANT STRAINS OF PSEUDOMONAS AERUGINOSA
by: Fazle Bari, et al.
Published: (2019-06-01)